RNS Number : 1802U
Port Erin Biopharma Investments Ltd
16 December 2011
16 December 2011
Port Erin Biopharma Investments Limited
("Port Erin" or the "Company")
Change of Quarterly NAV valuation
The Board of Port Erin has agreed with its Nominated Adviser to change the quarter day NAV valuation from 15 December 2011 and every three months thereafter to coincide with calendar quarters. It therefore proposes to release an NAV valuation and a full breakdown of investments made as at 31 December 2011 in the first half of January 2012.
Enquiries:
|
Port Erin Biopharma Investments |
|
|
Tom Winnifrith, CIO |
+44 7624 355306 |
|
Libertas Capital Corporate Finance Limited |
|
|
Sandy Jamieson |
+44 207 569 9650 |
|
Rivington Street Corporate Finance Limited |
|
|
Jon Levinson |
+44 207 562 3389 |
This information is provided by RNS
The company news service from the London Stock Exchange